BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis

B cell CLL/lymphoma 6 member B (BCL6B) is expressed in many normal tissues but expressed at very low levels in cancer tissues. It was reported that BCL6B inhibits hepatocellular carcinoma (HCC) metastases, but the exact role of BCL6B in HCC remains to be investigated. BCL6B expression was significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weilin, Huang, Pengfei, Wu, Panyisha, Kong, Rong, Xu, Jiang, Zhang, Lufei, Yang, Qifan, Xie, Qingsong, Zhang, Linshi, Zhou, Xiaohu, Chen, Linghui, Xie, Haiyang, Zhou, Lin, Zheng, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653002/
https://www.ncbi.nlm.nih.gov/pubmed/25970780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653002/
https://www.ncbi.nlm.nih.gov/pubmed/25970780

Ejemplares similares